Early Vitrectomy Versus Laser Photocoagulation for Proliferative Diabetic Retinopathy: A Prospective, Randomized Study
Background: Proliferative diabetic retinopathy (PDR) requires treatment to preserve visual function, but the comparative outcomes of panretinal photocoagulation (PRP) and different early vitrectomy strategies remain incompletely characterised. Objective: To compare functional and anatomical outcomes and postoperative complications following PRP and four vitrectomy-based approaches. Methods: In this prospective, randomised study, 121 patients with PDR were allocated to vitrectomy without PRP (n = 22), vitrectomy with deferred PRP (n = 24), vitrectomy with intraoperative PRP (n = 26), preoperative anti-vascular endothelial growth factor injection followed by vitrectomy without PRP (n = 22), or three sessions of PRP alone (n = 27). Best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were assessed at baseline and at 1, 3 and 6 months. Postoperative complications were recorded. Results: At 6 months, BCVA improved significantly only in the PRP-only group, from 0.45 ± 0.25 to 0.60 ± 0.24 (P < 0.05). CRT decreased significantly following vitrectomy with intraoperative PRP (287 ± 31.25 to 229 ± 11.11 μm) and with deferred PRP (242 ± 17.2 to 211 ± 12.1 μm), both P < 0.05. Vitreous haemorrhage occurred in 11.1% of patients receiving PRP alone, while ocular hypertension occurred in 13.6% following vitrectomy without PRP. Conclusion: PRP demonstrated the greatest improvement in BCVA at 6 months. Significant anatomical improvement, characterised by CRT reduction, was observed following vitrectomy with intraoperative PRP. Vitrectomy without PRP was associated with a higher incidence of postoperative complications. These findings suggest complementary roles for laser therapy and vitrectomy in PDR management.
Authors
- Vyacheslav O. Ponomarev (ORCID: https://orcid.org/0000-0002-2353-9610)
- Ulrich H. Spandau
- Ekaterina G. Kovalenko
- Viktor N. Kazaikin
Publication Details
- Published
- 2026-11-19
- DOI
- https://doi.org/10.9734/ajrrop/2026/v9i1171
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00